Wharton's Jelly MSCs: Potential Weapon to Sharpen for Our Battle against DM

Document Type

Article

Publication Date

4-1-2020

Abstract

© 2020 Elsevier Ltd Diabetes mellitus (DM) is a devastating metabolic disease. Stem cell therapy provides great hope to all diabetic patients. Umbilical cord (UC) Wharton's jelly mesenchymal stem cells (WJ-MSCs) specifically provides a potential cell therapy for DM. In this article, we discuss major advantages of WJ-MSCs and challenges facing their clinical utility in DM.

This document is currently not available here.

Share

COinS